A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Drug Monitoring, Opioids Panel, with Confirmation, Urine
Test Code39013
CPT Codes
80307
Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Buprenorphine, Fentanyl, Heroin Metabolite, Methadone, Methorphan, Mitragynine, Opiates, Tapentadol, Tramadol
If screening drug class result is equal to or greater than the cutoff, then confirmation testing will be performed at an additional charge (CPT code(s): dependent on the drug class being confirmed - Buprenorphine/Naloxone - 80348, 80362, Fentanyl - 80354, Heroin Metabolite - 80356, Methadone - 80358, Methorphan - 80362, Mitragynine - 80362, Opiates - 80361, 80365, Tapentadol - 80372, Tramadol - 80373 or HCPCS: G0480)
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Buprenorphine, Fentanyl, Heroin Metabolite, Methadone, Methorphan, Mitragynine, Opiates, Tapentadol, Tramadol
If screening drug class result is equal to or greater than the cutoff, then confirmation testing will be performed at an additional charge (CPT code(s): dependent on the drug class being confirmed - Buprenorphine/Naloxone - 80348, 80362, Fentanyl - 80354, Heroin Metabolite - 80356, Methadone - 80358, Methorphan - 80362, Mitragynine - 80362, Opiates - 80361, 80365, Tapentadol - 80372, Tramadol - 80373 or HCPCS: G0480)
Preferred Specimen
1 mL random urine in a clinical drug test transport vial
Minimum Volume
0.5 mL
Instructions
Collect specimen in a urine collection container and transfer to a clinical drug test transport vial
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 21 days
Refrigerated: 14 days
Frozen: 21 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Preserved samples
Methodology
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues-Sun; Report available: 3 days
Clinical Significance
Monitoring of parent compounds and their metabolites in urine. The results of this test are used in specific treatment programs to determine compliance with prescribed dosing schedules.